Emergence of TP53 mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization Montgomery Cancer Center, Prattville Campus, Prattville, AL To create an adaptation, translation, or derivative of the original work, for commercial e-prints and printed articles further permission is required. For information contact: marketing@haematologica.org